7Baggers

We provide you with 20 years of free, institutional-grade data for NYXH stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NYXH. Explore the full financial landscape of NYXH stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
Login to see more insider transactions
The information provided in this report about NYXH stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Nyxoah
(NASDAQ:NYXH) 

NYXH stock logo

We are a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, or OSA. Our lead solution is the Genio system, a CE-Marked, patient-centric minimally invasive next- generation hypoglossal neurostimulation therapy for the ...

Founded: 2009
CEO: Olivier Taelman  
Sector:
Industry:

Share this website to your friends